Investors
A software company making molecular discovery computable.
Acellera builds the products and underlying molecular simulation ecosystem, then tests them on real program decisions and publishes the evidence.
01 Where we are
Evidence before claims.
The company has built molecular simulation software since 2006. Today the stack includes PlayMolecule® AI, QuantumBind® Lab and ACEMD® Toolkit, supported by peer reviewed research and internal program evidence.
Our public story is growth: more useful software, repeatable customer adoption and evidence that compounds and programs can test. We speak with investors and strategic partners who share that long term view.
If you think you might be the right partner, let us start a conversation: investors@acellera.com.
in Barcelona
More than 18,000 researchers have used Acellera software. About the company